Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $625
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $600 to $625.
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $600 to $625.